A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma

Clinical trial NCT01425996 · TERMINATED

Trial details

NCT number: NCT01425996
Sponsor: Taiwan Liposome Company
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2011-10-27
Primary completion: 2014-10-03
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.